MAVERICK CAPITAL LTD NAMS — NEWAMSTERDAM PHARMA COMPANY

Ownership history in MAVERICK CAPITAL LTD  ·  5 quarters on record

AI Ownership Summary

MAVERICK CAPITAL LTD reported NEWAMSTERDAM PHARMA COMPANY (NAMS) in 5 quarterly 13F filings from 2024 Q4 through 2025 Q4. Peak portfolio weight reached 0.71% in 2025 Q4. The latest visible filing shows NAMS at 0.71% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this NAMS ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was MAVERICK CAPITAL LTD's position in NEWAMSTERDAM PHARMA COMPANY, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

NAMS was reported at 0.71% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.71% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

NAMS stock page MAVERICK CAPITAL LTD fund profile MAVERICK CAPITAL LTD full holdings
How MAVERICK CAPITAL LTD held NAMS — position size vs. price
% of Fund (quarterly)    NAMS price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 5 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 ADDED — — — 1,894,226 +389,479 +25.9% 0.71% $66.4M 2026-02-14 (Est.) $34.63
2025 Q3 REDUCED — — — 1,504,747 -27,127 -1.8% 0.57% $42.8M 2025-11-14 $38.35
2025 Q2 ADDED — — — 1,531,874 +982,405 +178.8% 0.42% $27.7M 2025-08-14 $25.17
2025 Q1 ADDED — — — 549,469 +199,464 +57.0% 0.20% $11.2M 2025-05-15 $18.70
2024 Q4 INITIATED — — — 350,005 — — 0.16% $9.0M 2025-02-14 $19.91

🏢 Other funds also holding NAMS

As of 2026 Q1 — sorted by position size

Medicxi Ventures Management (Jersey) Ltd 3Y 8.72% MOODY ALDRICH PARTNERS LLC 3Y 7Y 0.66% PSP Research LLC 0.34% Eleva Capital SAS 0.24% PTM WEALTH MANAGEMENT, LLC 0.23% PEREGRINE CAPITAL MANAGEMENT LLC 3Y 7Y 0.21% China Universal Asset Management Co., Ltd. 3Y 0.11% ALTFEST L J & CO INC 3Y 7Y 0.05% Handelsbanken Fonder AB 3Y 7Y 0.04% Aberdeen Group plc 3Y 7Y 0.04%

FAQ About MAVERICK CAPITAL LTD and NAMS

These are the practical questions this page is built to answer before you even open the full history table.

How long has MAVERICK CAPITAL LTD reported owning NAMS?

MAVERICK CAPITAL LTD reported NAMS across 5 quarterly 13F filings, from 2024 Q4 through 2025 Q4.

What was the largest reported NAMS position in MAVERICK CAPITAL LTD's portfolio?

The largest reported portfolio weight for NAMS was 0.71% in 2025 Q4.

What is the latest reported NAMS position on this page?

The most recent filing on this page is 2025 Q4, when MAVERICK CAPITAL LTD reported 1,894,226 shares, equal to 0.71% of portfolio, with an estimated market value of $66.4M.

What does the chart on this NAMS ownership page compare?

The chart compares MAVERICK CAPITAL LTD's quarterly NAMS portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did MAVERICK CAPITAL LTD time their NAMS position?

Based on 13F filing dates vs. subsequent NAMS price moves, MAVERICK CAPITAL LTD correctly timed 3 out of 4 reported position changes (75%). The annualised alpha on NAMS relative to SPY over the holding period was +53.8%.

← Back to MAVERICK CAPITAL LTD Holdings